Eli Lilly Oral Obesity Drug Market Expectations Reach $1.5B
Market expectations for Eli Lilly's oral obesity pill are approximately $1.5 billion for this year. The drug has only been on the market for two to three weeks. Analysts suggest reaching this revenue target may be difficult.
Topics
Developing
- 863d Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore.
- 863d Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
- 863d Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est.
- 863d Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium.
Sources · 7 independent
Bloomberg Radio
“Folks are looking for one and a half billion dollars from a lilies pill this year. And it's only been on the market for a couple of a couple of weeks, two or three weeks.”
Unlock the full story
Get a Pro subscription or above to see the live story progression and the full list of independent sources confirming each event as they happen.
Log in to upgrade